April 25, 2023
Sumitomo Pharma is restricting the shipments of Twymeeg (imeglimin), a novel diabetes treatment released in the fall of 2021. The drug has temporarily fallen into short supply because the number of its prescriptions significantly outpaced the company’s expectations. The Osaka...read more